Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yasufumi Enyama"'
Autor:
Yumie Takeshita, Yuki Kita, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, Chisato Teramura, Yasufumi Enyama, Toshinari Takamura, the Establishment of Rationale for Antiaging Diabetic Medicine (ERA‐DM) Study Group
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 6, Pp 965-974 (2022)
Abstract Aims/Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) might be less effective in patients with severe hyperglycemia, because hyperglycemia downregulated the GLP‐1 receptor in an animal study. To examine this hypothes
Externí odkaz:
https://doaj.org/article/eaedd379a2fb4663bf3d9039c36984f1
Autor:
Yumie Takeshita, Chisato Teramura, Kyoko Kamoshita, Hiroaki Takayama, Hiromi Nakagawa, Yasufumi Enyama, Kiyo‐Aki Ishii, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, Sachie Osada, Yoshiaki Tanaka, Kumpei Tokuyama, Toshinari Takamura
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 3, Pp 532-542 (2022)
ABSTRACT Aim Selenoprotein P (SeP, encoded by SELENOP in humans) is a hepatokine that causes insulin resistance in the liver and skeletal muscle. It was found that polyunsaturated fatty acid eicosapentaenoic acid (EPA) downregulates Selenop expressio
Externí odkaz:
https://doaj.org/article/2291939474354f1ba9a6bcaefcac3fa8
Autor:
Kyoko Kamoshita, Yumie Takeshita, Hiromi Nakagawa, Kiyo-aki Ishii, Sachie Osada, Chisato Teramura, Hiroaki Takayama, Yujiro Nakano, Hisanori Goto, Toshinari Takamura, Yasufumi Enyama, Takeo Tanaka, Yoshiaki Tanaka, Kumpei Tokuyama
Publikováno v:
Journal of Diabetes Investigation. 13:532-542
AIM Selenoprotein P (SeP, encoded by SELENOP in humans) is a hepatokine that causes insulin resistance in the liver and skeletal muscle. It was found that polyunsaturated fatty acid eicosapentaenoic acid (EPA) downregulates Selenop expression by inac
Autor:
Yumie Takeshita, Takehiro Kanamori, Takeo Tanaka, Saori Sako, Toshinari Takamura, Yasufumi Enyama
Publikováno v:
Endocrine Journal. 68:1225-1236
This randomized, open-label, and parallel-group study aimed to investigate the effects of altering the timing of carbohydrate intake at breakfast or dinner on blood glucose fluctuations and energy metabolism. A total of 43 participants with type 2 di
Autor:
Yasufumi Enyama, Yumie Takeshita, Takeo Tanaka, Saori Sako, Takehiro Kanamori, Toshinari Takamura
Publikováno v:
Endocrine Journal; 2021, Vol. 68 Issue 10, p1225-1236, 12p
Autor:
Kensuke Mohri, Toshinari Takamura, Yasufumi Enyama, Fei Lan, Yoshiro Saito, Akihiro Kikuchi, Hirofumi Misu, Hiroaki Takayama, Shuichi Kaneko, Yumie Takeshita, Kiyo-aki Ishii
Publikováno v:
Biologicalpharmaceutical bulletin. 42(3)
A hepatokine is a collective term for liver-derived secretory factors whose previously-unrecognized functions have been recently elucidated. We have rediscovered selenoprotein P (SeP) and leukocyte cell-derived chemotaxin 2 (LECT2) as hepatokines tha